Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Watzka, SB; Posch, F; Pass, HI; Flores, RM; Hannigan, GE; Bernhard, D; Weber, M; Mueller, MR.
Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
Eur J Cardiothorac Surg. 2013; 43(5):940-945 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Posch Florian
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Number of Figures: 2
| |
Abstract:
Integrin-linked kinase (ILK) is an intracellular protein implicated in chronic inflammation and neoplastic transformation. In a recently accomplished pilot study, we showed that ILK can be detected in the serum of patients with benign and malignant chest diseases, including malignant pleural mesothelioma (MPM). Interestingly, average serum ILK concentrations were 10 times higher in MPM patients when compared with the rest of the study population, and a diagnostic test solely based on serum ILK concentration could discriminate between MPM and non-MPM with considerable accuracy. This study aimed to investigate whether serum ILK concentration could also be used to discriminate between MPM and asbestos exposure only. Using a self-developed sandwich enzyme-linked immunosorbent assay, we measured serum ILK concentrations in 101 MPM patients, and 96 asbestos-exposed, but healthy insulation workers. Seventy-three MPM patients had an epitheloid subtype (72.3%), and 42 had a Stage I or II disease (41.6%). When compared with asbestos-exposed individuals, MPM patients of all clinical stages had significantly higher (mean ± standard deviation, median) serum ILK concentrations (10.7 ± 13.6, median 7 ng/ml vs 3.1 ± 4.6, median 1.4 ng/ml; P < 0.001). Among MPM patients, the serum ILK concentration was significantly higher at advanced disease stages III + IV than at early stages I + II (13.7 ± 15.9, median 8.5 ng/ml vs 6.7 ± 7.8, median 3.5 ng/ml; P = 0.02). Using serum ILK to discriminate between MPM patients and asbestos-exposed individuals yielded an area under the curve of 0.69 (95% confidence interval 0.63-0.76). The corresponding sensitivity and specificity for a cut-off of 4.49 ng/ml ILK are 61.4 and 80.2%, respectively. These data show significant differences between MPM patients and asbestos-exposed but healthy individuals concerning their serum ILK concentration. Furthermore, since ILK levels are increased in advanced MPM stages in comparison with early MPM stages, we suggest evaluating its potential use as a marker of disease progression in MPM.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Air Pollutants, Occupational - analysis Air Pollutants, Occupational - blood Air Pollutants, Occupational - poisoning
Analysis of Variance -
Asbestos - poisoning
Case-Control Studies -
Diagnosis, Differential -
Enzyme-Linked Immunosorbent Assay -
Female -
Humans -
Male -
Mesothelioma - blood Mesothelioma - enzymology Mesothelioma - etiology
Middle Aged -
Occupational Exposure - analysis
Pleural Neoplasms - blood Pleural Neoplasms - enzymology Pleural Neoplasms - etiology
Protein-Serine-Threonine Kinases - blood
ROC Curve -
Sensitivity and Specificity -

Find related publications in this database (Keywords)
Malignant pleural mesothelioma
Integrin-linked kinase
Asbestos exposure
Differential diagnosis
ELISA
© Med Uni Graz Impressum